Glucagon-like peptide-1 agonism - GLP-1, common in obesity medicines - is not essential to weight management, according to preclinical research led by Richard DiMarchi and Matthias Tschöp, with funding from their startup company Bluewater Biosciences.
It’s the zeitgeist of the AI age; outsourcing our intention and tomorrowing our resolve.
I find the fact you’ve learned to speak clickbait concerning
Be less concerned, I was going for Bumper Sticker or T-Shirt slogan.
I don’t know whether that’s a quote from something or fresh off the dome but that’s an absolute banger of a line.
It is a fresh assembly of deeper thoughts by smarter people. So it’s just an internet comment essentially.